Physiological role for the cochaperone FKBP52 in androgen receptor signaling

被引:164
作者
Cheung-Flynn, J
Prapapanich, V
Cox, MB
Riggs, DL
Suarez-Quian, C
Smith, DF
机构
[1] Mayo Clin Scottsdale, Coll Med, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA
[2] Georgetown Univ, Med Ctr, Dept Cell Biol, Washington, DC 20057 USA
关键词
D O I
10.1210/me.2005-0071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Molecular chaperones mediate multiple aspects of steroid receptor function, but the physiological importance of most receptor-associated cochaperones has not been determined. To help fill this gap, we targeted for disruption the mouse gene for the 52-kDa FK506 binding protein, FKBP52, a 90-kDa heat shock protein (Hsp90)-binding immunophilin found in steroid receptor complexes. A mouse line lacking FKBP52 (52KO) was generated and characterized. Male 52KO mice have several defects in reproductive tissues consistent with androgen insensitivity; among these defects are ambiguous external genitalia and dysgenic prostate. FKBP52 and androgen receptor (AR) are coexpressed in prostate epithelial cells of wild-type mice. However, FKBP52 and AR are similarly coexpressed in testis even though testis morphology and spermatogenesis in 52KO males are usually normal. Molecular studies confirm that FKBP52 is a component of AR complexes, and cellular studies in yeast and human cell models demonstrate that FKBP52 can enhance AR-meditated transactivation. AR enhancement requires FKBP52 peptidylprolyl isomerase activity as well as Hsp90-binding ability, and enhancement probably relates to an affect of FKBP52 on AR-folding pathways. In the presence of FKBP52, but not other cochaperones, the function of a minimally active AR point mutant can be dramatically restored. We conclude that FKBP52 is an AR folding factor that has critically important physiological roles in some male reproductive tissues.
引用
收藏
页码:1654 / 1666
页数:13
相关论文
共 48 条
[1]   Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome [J].
Ahmed, SF ;
Cheng, A ;
Dovey, L ;
Hawkins, JR ;
Martin, H ;
Rowland, J ;
Shimura, N ;
Tait, AD ;
Hughes, IA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :658-665
[2]  
Alberti S, 2003, CELL STRESS CHAPERON, V8, P225, DOI 10.1379/1466-1268(2003)008<0225:BNEFOH>2.0.CO
[3]  
2
[4]   Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2) [J].
Berrevoets, CA ;
Doesburg, P ;
Steketee, K ;
Trapman, J ;
Brinkmann, AO .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (08) :1172-1183
[5]   The biomarker and endocrine disruptors in mammals [J].
Choi, KC ;
Jeung, EB .
JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2003, 49 (05) :337-345
[6]   FKBP52 [J].
Davies, TH ;
Sánchez, ER .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (01) :42-47
[7]   A new first step in activation of steroid receptors -: Hormone-induced switching of FKBP51 and FKBP52 immunophilins [J].
Davies, TH ;
Ning, YM ;
Sánchez, ER .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) :4597-4600
[8]   Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor [J].
Doesburg, P ;
Kuil, CW ;
Berrevoets, CA ;
Steketee, K ;
Faber, PW ;
Mulder, E ;
Brinkmann, AO ;
Trapman, J .
BIOCHEMISTRY, 1997, 36 (05) :1052-1064
[9]   Hsp90 regulates androgen receptor hormone binding affinity in vivo [J].
Fang, YF ;
Fliss, AE ;
Robins, DM ;
Caplan, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) :28697-28702
[10]  
Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO